252 related articles for article (PubMed ID: 34407796)
1. Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
Feng G; Xu Y; Ma N; Midorikawa K; Oikawa S; Kobayashi H; Nakamura S; Ishinaga H; Zhang Z; Huang G; Takeuchi K; Murata M
BMC Cancer; 2021 Aug; 21(1):929. PubMed ID: 34407796
[TBL] [Abstract][Full Text] [Related]
2. Combination of Plasma MIF and VCA-IgA Improves the Diagnostic Specificity for Patients With Nasopharyngeal Carcinoma.
Xue N; Xing S; Ma W; Sheng J; Huang Z; Xu Q
Technol Cancer Res Treat; 2020; 19():1533033820935773. PubMed ID: 32578505
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population.
Svajdler M; Kaspirkova J; Mezencev R; Laco J; Torday T; Dubinsky P; Straka L; Ondic O; Michal M; Skalova A
Neoplasma; 2016; 63(1):107-14. PubMed ID: 26639240
[TBL] [Abstract][Full Text] [Related]
4. Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.
Xue N; Lin JH; Xing S; Liu D; Li SB; Lai YZ; Wang XP; Mao MJ; Zhong Q; Zeng MS; Liu WL
Cancer Res Treat; 2019 Jan; 51(1):378-390. PubMed ID: 29807404
[TBL] [Abstract][Full Text] [Related]
5. Viral markers in nasopharyngeal carcinoma: A systematic review and meta-analysis on the detection of p16
Tham T; Machado R; Russo DP; Herman SW; Teegala S; Costantino P
Am J Otolaryngol; 2021; 42(1):102762. PubMed ID: 33202328
[TBL] [Abstract][Full Text] [Related]
6. The influence of human papillomavirus on nasopharyngeal carcinoma in Japan.
Kano M; Kondo S; Wakisaka N; Moriyama-Kita M; Nakanishi Y; Endo K; Murono S; Nakamura H; Yoshizaki T
Auris Nasus Larynx; 2017 Jun; 44(3):327-332. PubMed ID: 27499435
[TBL] [Abstract][Full Text] [Related]
7. Necrosis Factor-α (TNF-α) and the Presence of Macrophage M2 and T Regulatory Cells in Nasopharyngeal Carcinoma.
Mardhiyah I; Ardiyan YN; Aliyah SH; Sitepu EC; Herdini C; Dwianingsih EK; Asfarina F; Sumartiningsih S; Fachiroh J; Paramita DK
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2363-2370. PubMed ID: 34452547
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.
Simon J; Schroeder L; Ingarfield K; Diehl S; Werner J; Brenner N; Liu Z; Pawlita M; Pring M; Butt J; Ness A; Waterboer T
Int J Cancer; 2020 Jul; 147(2):461-471. PubMed ID: 32279316
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma.
Pei XJ; Wu TT; Li B; Tian XY; Li Z; Yang QX
Int J Med Sci; 2014; 11(1):106-15. PubMed ID: 24396292
[TBL] [Abstract][Full Text] [Related]
10. Clinical Value of the Epstein-Barr Virus and p16 Status in Patients with Nasopharyngeal Carcinoma: A Single-Centre Study in Japan.
Saito Y; Ushiku T; Omura G; Yasuhara K; Yoshida M; Takahashi W; Ando M; Fukayama M; Yamasoba T
ORL J Otorhinolaryngol Relat Spec; 2016; 78(6):334-343. PubMed ID: 28171876
[TBL] [Abstract][Full Text] [Related]
11. Association of Plasma Epstein-Barr Virus LMP1 and EBER1 with Circulating Tumor Cells and the Metastasis of Nasopharyngeal Carcinoma.
Sun L; Wang Y; Shi J; Zhu W; Wang X
Pathol Oncol Res; 2020 Jul; 26(3):1893-1901. PubMed ID: 31832991
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland.
Ruuskanen M; Irjala H; Minn H; Vahlberg T; Randen-Brady R; Hagström J; Syrjänen S; Leivo I
Head Neck; 2019 Feb; 41(2):349-357. PubMed ID: 30549170
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Significance of IGF-1R and Relationship with Epstein-Barr Virus Markers: LMP1 and EBERs in Tunisian Patients with Nasopharyngeal Carcinoma.
Baizig NM; Wided BA; Amine OE; Gritli S; ElMay M
Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):1011-1019. PubMed ID: 32468823
[TBL] [Abstract][Full Text] [Related]
14. Circulation EBV Mir-Bart-7 Relating to Clinical Manifestation in Nasopharyngeal Carcinoma.
Wardana T; Gunawan L; Herawati C; Oktriani R; Anwar S; Astuti I; Aryandono T; Mubarika S
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2777-2782. PubMed ID: 32986380
[TBL] [Abstract][Full Text] [Related]
15. M2-polarized tumour-associated macrophages in stroma correlate with poor prognosis and Epstein-Barr viral infection in nasopharyngeal carcinoma.
Huang H; Liu X; Zhao F; Lu J; Zhang B; Peng X; Zhang M; Chen X; Li G; Li X
Acta Otolaryngol; 2017 Aug; 137(8):888-894. PubMed ID: 28395580
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
Guo J; Cui Z; Zheng Y; Li X; Chen Y
Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.
Huang SH; Jacinto JCK; O'Sullivan B; Su J; Kim J; Ringash J; Spreafico A; Yu E; Perez-Ordonez B; Weinreb I; Cho J; Hope AJ; Bratman SV; Giuliani ME; Hosni A; Hahn E; Goldstein DP; Tong L; Eng L; Xu W; Waldron JN
Cancer; 2022 Aug; 128(15):2908-2921. PubMed ID: 35588085
[TBL] [Abstract][Full Text] [Related]
18. Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer.
Nahand JS; Khanaliha K; Mirzaei H; Moghoofei M; Baghi HB; Esghaei M; Khatami AR; Fatemipour M; Bokharaei-Salim F
BMC Cancer; 2021 Aug; 21(1):926. PubMed ID: 34399719
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus Induces Adipocyte Dedifferentiation to Modulate the Tumor Microenvironment.
Liu SC; Tsang NM; Lee PJ; Sui YH; Huang CH; Liu TT
Cancer Res; 2021 Jun; 81(12):3283-3294. PubMed ID: 33824135
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma: A Brief Review.
Xue F; He X
Methods Mol Biol; 2020; 2204():99-107. PubMed ID: 32710318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
